Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
New York: Ahead of Christmas, stranded NASA astronauts Sunita Williams and Butch Wilmore turned Santa…
Hyderabad: There’s no respite for BRS leader KT Rama Rao (KTR) in the case linked…
Sambalpur: The Indian Institute of Management (IIM) at Sambalpur in Odisha has announced changes in…
Mumbai: Arjun Kapoor, who broke up with girlfriend Malaika Arora, impressed movie buffs and critics…
Mumbai: ‘Citadel: Honey Bunny’ actor Varun Dhawan, who has been in the industry for a…
New Delhi: Delhi Police on Friday transferred the FIR filed against Congress leader Rahul Gandhi…
This website uses cookies.